Foti G, Ascenti G, Agostini A, Longo C, Lombardo F, Inno A
Tomography. 2024; 10(3):299-319.
PMID: 38535766
PMC: 10975567.
DOI: 10.3390/tomography10030024.
Suto H, Inui Y, Okamura A
Front Oncol. 2023; 13:1158797.
PMID: 37152012
PMC: 10157226.
DOI: 10.3389/fonc.2023.1158797.
Arslan S, Sarikaya Y, Akata D, Ozmen M, Karcaaltincaba M, Karaosmanoglu A
Abdom Radiol (NY). 2022; 47(4):1473-1502.
PMID: 35230499
DOI: 10.1007/s00261-022-03462-z.
Freitas P, Janicas C, Veiga J, Matos A, Heredia V, Ramalho M
World J Hepatol. 2022; 13(12):1936-1955.
PMID: 35069999
PMC: 8727197.
DOI: 10.4254/wjh.v13.i12.1936.
Cinli T, Yokus O, Goze H, Huq G, Serin I
Turk J Haematol. 2021; 39(1):78-79.
PMID: 34753278
PMC: 8886281.
DOI: 10.4274/tjh.galenos.2021.2021.0545.
Liver segmentation and metastases detection in MR images using convolutional neural networks.
Jansen M, Kuijf H, Niekel M, Veldhuis W, Wessels F, Viergever M
J Med Imaging (Bellingham). 2019; 6(4):044003.
PMID: 31620549
PMC: 6792006.
DOI: 10.1117/1.JMI.6.4.044003.
Early detection of intrahepatic cholangiocarcinoma.
Hamaoka M, Kozaka K, Matsui O, Komori T, Matsubara T, Yoneda N
Jpn J Radiol. 2019; 37(10):669-684.
PMID: 31372893
DOI: 10.1007/s11604-019-00860-0.
Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers.
Kim Y, Park M, Aljoqiman K, Choi J, Kim M
Clin Mol Hepatol. 2019; 25(3):223-233.
PMID: 30661336
PMC: 6759431.
DOI: 10.3350/cmh.2018.0107.
Liver Imaging Techniques: Recognition of Uveal Melanoma Metastases.
Bellerive C, Ouellet E, Kamaya A, Singh A
Ocul Oncol Pathol. 2019; 4(4):254-260.
PMID: 30643771
PMC: 6322083.
DOI: 10.1159/000485424.
Liver involvement by multiple myeloma presenting as hypervascular focal lesions in a patient with chronic hepatitis B infection.
Marcon M, Cereser L, Girometti R, Cataldi P, Volpetti S, Bazzocchi M
BJR Case Rep. 2018; 2(3):20150013.
PMID: 30459962
PMC: 6243346.
DOI: 10.1259/bjrcr.20150013.
Chronic active hepatitis induced by Pazopanib mimicking hypervascular liver metastases in a patient with recurrent soft tissue sarcoma: A case report.
Ezponda A, De La Huebra I, Calvo M, Idoate M, Vivas I
Oncol Lett. 2018; 16(3):4043-4048.
PMID: 30128026
PMC: 6096083.
DOI: 10.3892/ol.2018.9114.
18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
Kirchner J, Sawicki L, Deuschl C, Gruneisen J, Beiderwellen K, Lauenstein T
PLoS One. 2017; 12(7):e0180349.
PMID: 28683109
PMC: 5500282.
DOI: 10.1371/journal.pone.0180349.
Image quality and diagnostic performance of free-breathing diffusion-weighted imaging for hepatocellular carcinoma.
Takayama Y, Nishie A, Asayama Y, Ishigami K, Kakihara D, Ushijima Y
World J Hepatol. 2017; 9(14):657-666.
PMID: 28588750
PMC: 5437610.
DOI: 10.4254/wjh.v9.i14.657.
Non-Hypervascular Hypointense Nodules at Gadoxetic Acid MRI: Hepatocellular Carcinoma Risk Assessment with Emphasis on the Role of Diffusion-Weighted Imaging.
Briani C, Di Pietropaolo M, Marignani M, Carbonetti F, Begini P, David V
J Gastrointest Cancer. 2017; 49(3):302-310.
PMID: 28547117
DOI: 10.1007/s12029-017-9952-7.
Clinical Translation of an Albumin-Binding PET Radiotracer 68Ga-NEB.
Zhang J, Lang L, Zhu Z, Li F, Niu G, Chen X
J Nucl Med. 2015; 56(10):1609-14.
PMID: 26251416
PMC: 5238512.
DOI: 10.2967/jnumed.115.159640.
Diffusion weighted MR and apparent diffusion coefficient measurement in classification and characterization of noncystic focal liver lesions: does a clinical role exist?.
Mungai F, Morone M, Villanacci A, Bondioni M, Mazzoni L, Grazioli L
Medicine (Baltimore). 2014; 93(6):e40.
PMID: 25058143
PMC: 4602426.
DOI: 10.1097/MD.0000000000000040.
Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience.
Grieser C, Steffen I, Kramme I, Blaker H, Kilic E, Perez Fernandez C
Eur Radiol. 2014; 24(6):1339-48.
PMID: 24658870
DOI: 10.1007/s00330-014-3144-7.
SSAT/AHPBA joint symposium on evaluation and treatment of benign liver lesions.
Chun Y, House M, Kaur H, Loyer E, Paradis V, Vauthey J
J Gastrointest Surg. 2013; 17(4):636-44.
PMID: 23377783
PMC: 3628697.
DOI: 10.1007/s11605-013-2153-1.
MR elastography of liver tumours: value of viscoelastic properties for tumour characterisation.
Garteiser P, Doblas S, Daire J, Wagner M, Leitao H, Vilgrain V
Eur Radiol. 2012; 22(10):2169-77.
PMID: 22572989
DOI: 10.1007/s00330-012-2474-6.
[Benign focal hepatic lesions].
Baroud S, Bastati N, Prosch H, Schima W, Ba-Ssalamah A
Radiologe. 2011; 51(8):688-96.
PMID: 21809146
DOI: 10.1007/s00117-010-2127-1.